{"hands_on_practices": [{"introduction": "Ethical decisions surrounding novel medical interventions like germline editing often hinge on a fundamental trade-off between immense potential benefits and significant risks. A consequentialist framework provides a structured way to analyze this dilemma by quantifying and comparing the expected outcomes. This exercise [@problem_id:5028128] challenges you to apply the principles of expected utility to derive a clear decision rule, determining the maximum acceptable probability of harm, $p$, for a procedure to be considered ethically permissible.", "problem": "A clinical ethics board is evaluating whether Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) germline editing should be approved to correct a pathogenic variant that causes a severe early-onset monogenic disorder. In a simplified consequentialist framework grounded in expected utility, let the expected net benefit in Quality-Adjusted Life Years (QALYs) be modeled as $E=(1-p)B - pC$, where $p$ is the probability of a severe editing-related harm that would negate the intended benefit, $B$ is the QALYs gained if editing succeeds relative to no intervention, and $C$ is the QALYs lost if the severe harm occurs. Assume $B$ and $C$ are ethically-weighted QALYs for the future person, consistent with standard decision theory and utilitarian consequentialism.\n\nStarting from the foundational definition of expected value and the decision rule to intervene only when the expected net QALYs satisfy $E>0$, derive the permissibility threshold $p^{\\ast}$ as a function of $B$ and $C$. Then, for the specified scenario with $B=24$ QALYs and $C=80$ QALYs, compute $p^{\\ast}$ and report it as a unitless decimal rounded to four significant figures. Express your final answer without a percentage sign.", "solution": "The ethical analysis uses the consequentialist principle that an action is justified if it maximizes expected utility, here quantified as Quality-Adjusted Life Years (QALYs). The expected net QALYs, $E$, are modeled as the benefit $B$ gained with probability $(1-p)$ minus the cost of harm $C$ incurred with probability $p$:\n$$\nE=(1-p)B - pC\n$$\nThe decision rule is to permit the intervention only if the expected net QALYs are positive, i.e., $E > 0$. We can use this inequality to solve for the maximum permissible probability of harm, $p$.\n$$\n(1-p)B - pC > 0\n$$\nExpand and rearrange the terms to solve for $p$:\n$$\nB - pB - pC > 0\n$$\n$$\nB > pB + pC\n$$\n$$\nB > p(B+C)\n$$\n$$\n\\frac{B}{B+C} > p\n$$\nThis means the intervention is ethically permissible only if the probability of harm $p$ is less than the threshold $p^{\\ast} = \\frac{B}{B+C}$.\n\nFor the given scenario, the benefit is $B=24$ QALYs and the cost of harm is $C=80$ QALYs. We can now compute the value of the permissibility threshold $p^{\\ast}$:\n$$\np^{\\ast} = \\frac{24}{24+80} = \\frac{24}{104}\n$$\nSimplify the fraction:\n$$\n\\frac{24}{104} = \\frac{3 \\times 8}{13 \\times 8} = \\frac{3}{13}\n$$\nConverting the fraction to a decimal gives:\n$$\n\\frac{3}{13} \\approx 0.230769\\ldots\n$$\nRounding to four significant figures as required:\n$$\np^{\\ast} \\approx 0.2308\n$$\nThus, under this model, the procedure is ethically permissible only if the probability of severe harm is less than $0.2308$.", "answer": "$$\\boxed{0.2308}$$", "id": "5028128"}, {"introduction": "Beyond the decision to approve a technology lies the equally complex ethical question of its distribution. When a powerful resource like germline editing is limited, how do we allocate it justly? This practice [@problem_id:5028047] moves our focus from individual risk assessment to societal fairness by applying John Rawls’s influential difference principle. You will engage in a 'maximin' analysis to find the optimal allocation that gives the greatest benefit to the least advantaged members of society, providing a powerful alternative to purely utilitarian calculations.", "problem": "A public health authority must decide how to allocate a fixed capacity of $C = 100$ germline editing procedures across two subpopulations during a single planning period. Subpopulation $L$ is the least advantaged group, with a higher burden of severe, early-onset Mendelian disorders; subpopulation $H$ is the more advantaged group, with lower genetic disease burden. In medical genetics and health policy, an ethically relevant outcome proxy is Healthy Life Years (HLY), defined as the expected lifetime years lived in good health. Assume fractional allocation is feasible because the plan aggregates over many cycles and clinics.\n\nLet the baseline expected Healthy Life Years (HLY) in the absence of editing be $W_{L}^{0} = 45$ for subpopulation $L$ and $W_{H}^{0} = 65$ for subpopulation $H$. Due to triage that prioritizes the most severe variants first and the diminishing returns typical in risk-targeted interventions, the incremental HLY gains from allocating $x$ edits to $L$ and $C - x$ edits to $H$ follow concave functions:\n$$\ng_{L}(x) = 3\\sqrt{x}, \\quad g_{H}(C-x) = \\sqrt{C - x}.\n$$\nThus, the post-allocation well-being levels are\n$$\nW_{L}(x) = W_{L}^{0} + g_{L}(x) = 45 + 3\\sqrt{x}, \\quad W_{H}(x) = W_{H}^{0} + g_{H}(C-x) = 65 + \\sqrt{100 - x}.\n$$\n\nUse the core definition of John Rawls’s difference principle (“social and economic inequalities are to be arranged so that they are to the greatest benefit of the least advantaged”) operationalized by the maximin criterion (choose the policy that maximizes the minimum of group outcomes) to determine the ethically optimal allocation $x^{\\ast}$ to subpopulation $L$. Your answer should be the exact closed-form analytic expression for $x^{\\ast}$ that maximizes\n$$\n\\min\\big(W_{L}(x),\\, W_{H}(x)\\big).\n$$\nProvide only the value of $x^{\\ast}$ as your final answer. If you choose to approximate numerically instead of giving an exact closed form, round your answer to four significant figures and report it as a pure number of edits.", "solution": "The problem asks for the allocation $x^{\\ast}$ that maximizes the minimum of the two well-being functions, $W_L(x)$ and $W_H(x)$, according to the Rawlsian maximin criterion. The function to maximize is $F(x) = \\min(W_L(x), W_H(x))$, where $W_L(x) = 45 + 3\\sqrt{x}$ and $W_H(x) = 65 + \\sqrt{100-x}$.\n\nThe function $W_L(x)$ is monotonically increasing, while $W_H(x)$ is monotonically decreasing. Therefore, the maximum of their minimum occurs at the point $x^{\\ast}$ where the two functions are equal:\n$$\nW_L(x^{\\ast}) = W_H(x^{\\ast})\n$$\n$$\n45 + 3\\sqrt{x} = 65 + \\sqrt{100 - x}\n$$\nTo solve for $x$, first isolate the radical terms:\n$$\n3\\sqrt{x} - \\sqrt{100 - x} = 20\n$$\nIsolate one radical and square both sides:\n$$\n3\\sqrt{x} - 20 = \\sqrt{100 - x}\n$$\nSquaring both sides gives:\n$$\n(3\\sqrt{x} - 20)^2 = 100 - x\n$$\n$$\n9x - 120\\sqrt{x} + 400 = 100 - x\n$$\nRearrange to form a quadratic-in-form equation:\n$$\n10x - 120\\sqrt{x} + 300 = 0\n$$\nDivide by 10 to simplify:\n$$\nx - 12\\sqrt{x} + 30 = 0\n$$\nLet $y = \\sqrt{x}$. The equation becomes a quadratic in $y$:\n$$\ny^2 - 12y + 30 = 0\n$$\nUsing the quadratic formula, $y = \\frac{-b \\pm \\sqrt{b^2 - 4ac}}{2a}$:\n$$\ny = \\frac{12 \\pm \\sqrt{(-12)^2 - 4(1)(30)}}{2} = \\frac{12 \\pm \\sqrt{144 - 120}}{2} = \\frac{12 \\pm \\sqrt{24}}{2}\n$$\nSimplifying $\\sqrt{24} = 2\\sqrt{6}$, we get:\n$$\ny = \\frac{12 \\pm 2\\sqrt{6}}{2} = 6 \\pm \\sqrt{6}\n$$\nWe have two potential solutions for $y=\\sqrt{x}$. However, from the step $3\\sqrt{x} - 20 = \\sqrt{100 - x}$, the left side must be non-negative, so $3\\sqrt{x} \\ge 20$, which implies $\\sqrt{x} \\ge 20/3 \\approx 6.67$.\n- The solution $y = 6 + \\sqrt{6} \\approx 8.45$ is valid.\n- The solution $y = 6 - \\sqrt{6} \\approx 3.55$ is extraneous and must be discarded.\n\nThus, the only valid solution is $\\sqrt{x^{\\ast}} = 6 + \\sqrt{6}$. Squaring this gives the optimal allocation $x^{\\ast}$:\n$$\nx^{\\ast} = (6 + \\sqrt{6})^2 = 36 + 12\\sqrt{6} + 6\n$$\n$$\nx^{\\ast} = 42 + 12\\sqrt{6}\n$$", "answer": "$$\n\\boxed{42 + 12\\sqrt{6}}\n$$", "id": "5028047"}, {"introduction": "The debate over germline editing intensifies when considering 'enhancements' that confer competitive advantages rather than curing disease. The individual incentive to gain a 'positional' edge can trigger complex societal dynamics, where personal choices have broad, often unintended, consequences. This practice [@problem_id:5028124] uses the tools of game theory to model such a scenario, revealing how individually rational decisions can paradoxically lead to a collective 'arms race.' By analyzing the payoffs associated with status benefits, $S$, and health risks, $H$, you will determine the conditions under which a society might become locked into a cycle of enhancement that leaves no one relatively better off.", "problem": "A medical genetics ethics committee is evaluating potential societal dynamics if heritable enhancement becomes technically feasible and legal. Consider two large populations, labeled $A$ and $B$, whose members are randomly matched across populations for status-sensitive competitions (for example, high-stakes admissions or employment). Each individual chooses between two strategies: adopt a heritable enhancement (strategy $E$) or refrain (strategy $N$). Let $S>0$ denote the benefit associated with being enhanced relative to a non-enhanced rival in a competitive interaction (a positional or status benefit), and let $H>0$ denote the expected health risk cost associated with adopting heritable enhancement.\n\nAssume the following individual-level payoffs per match:\n- If both individuals adopt ($E$ vs. $E$): each receives $-H$ (both incur health risk, no relative status advantage).\n- If you adopt and the rival does not ($E$ vs. $N$): you receive $S-H$, the rival receives $-S$.\n- If you do not adopt and the rival adopts ($N$ vs. $E$): you receive $-S$, the rival receives $S-H$.\n- If neither adopts ($N$ vs. $N$): each receives $0$.\n\nModel the situation as a symmetric $2 \\times 2$ game with random matching across the two populations. Using the definition of Nash equilibrium (a strategy profile where no individual can improve their expected payoff by unilaterally deviating) and expected utility from mixed strategies, derive the set of Nash equilibria as functions of $S$ and $H$. Define an “arms race escalation” as the case where the unique Nash equilibrium yields adoption with probability $1$ in both populations.\n\nLet $r^{\\ast}$ denote the critical ratio $S/H$ at which the equilibrium transitions from no adoption to arms race escalation. Determine $r^{\\ast}$. Report the value of $r^{\\ast}$ as a pure number (no units). No rounding is required.", "solution": "This scenario can be modeled as a symmetric $2 \\times 2$ game between two representative individuals (players), choosing between strategies to Enhance ($E$) or Not Enhance ($N$). The payoff matrix for the Row player is given as:\n\n$$\n\\begin{array}{c|cc}\n\\text{Row Player} \\backslash \\text{Column Player} & E & N \\\\\n\\hline\nE & -H & S-H \\\\\nN & -S & 0 \\\\\n\\end{array}\n$$\n\nWe can find the Nash equilibria by analyzing each player's best response to the other's strategy. A strategy is strictly dominant if it provides a better outcome than any other strategy, regardless of what the opponent does.\n\n1.  **If the opponent chooses $E$**: The player's payoff is $-H$ for choosing $E$ and $-S$ for choosing $N$. The player's best response is $E$ if $-H > -S$ (i.e., $S > H$), and $N$ if $-H  -S$ (i.e., $S  H$).\n\n2.  **If the opponent chooses $N$**: The player's payoff is $S-H$ for choosing $E$ and $0$ for choosing $N$. The player's best response is $E$ if $S-H > 0$ (i.e., $S > H$), and $N$ if $S-H  0$ (i.e., $S  H$).\n\nThis analysis reveals two distinct cases based on the relationship between the status benefit $S$ and the health cost $H$:\n\n-   **Case 1: $S > H$**\n    In this case, strategy $E$ is the best response regardless of the opponent's choice. Therefore, $E$ is a strictly dominant strategy. The unique Nash equilibrium is for both players to choose $E$. This is the \"arms race escalation\" scenario, resulting in the payoff profile $(-H, -H)$.\n\n-   **Case 2: $S  H$**\n    In this case, strategy $N$ is the best response regardless of the opponent's choice. Therefore, $N$ is a strictly dominant strategy. The unique Nash equilibrium is for both players to choose $N$. This is the \"no adoption\" scenario, resulting in the payoff profile $(0, 0)$.\n\nThe problem asks for the critical ratio $r^{\\ast} = S/H$ at which the equilibrium transitions from \"no adoption\" to \"arms race escalation\". This transition occurs at the boundary where the strategic incentive flips, which is precisely when $S = H$.\n\nWe can rephrase the conditions using the ratio $r = S/H$:\n-   Arms race escalation ($(E, E)$) is the unique equilibrium if $r > 1$.\n-   No adoption ($(N, N)$) is the unique equilibrium if $r  1$.\n\nThe critical ratio $r^{\\ast}$ that marks this transition is therefore $1$.\n$$ r^{\\ast} = 1 $$\nWhen $r > r^{\\ast}$, the positional benefit outweighs the health risk, making enhancement the individually rational choice, leading to a collectively suboptimal arms race. When $r  r^{\\ast}$, the health risk outweighs the benefit, making restraint the rational choice.", "answer": "$$\\boxed{1}$$", "id": "5028124"}]}